Viruses 2010, 2(4), 826-866; doi:10.3390/v2040826
Review

Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care

Rega Institute for Medical Research, KULeuven, Minderbroedersstraat 10, 3000 Leuven, Belgium These authors contributed equally to this work.
* Author to whom correspondence should be addressed.
Received: 15 December 2009; in revised form: 9 March 2010 / Accepted: 17 March 2010 / Published: 29 March 2010
(This article belongs to the Special Issue Hepatitis Viruses)
PDF Full-text Download PDF Full-Text [575 KB, uploaded 29 March 2010 10:01 CEST]
Abstract: Hepatitis C virus (HCV) represents a major health burden, with an estimated 180 million chronically infected individuals worldwide. These patients are at increased risk of developing liver cirrhosis and hepatocellular carcinoma. Infection with HCV is the leading cause of liver transplantation in the Western world. Currently, the standard of care (SoC) consists of pegylated interferon alpha (pegIFN-α) and ribavirin (RBV). However this therapy has a limited efficacy and is associated with serious side effects. Therefore more tolerable, highly potent inhibitors of HCV replication are urgently needed. Both Specifically Targeted Antiviral Therapy for HCV (STAT-C) and inhibitors that are believed to interfere with the host-viral interaction are discussed.
Keywords: HCV; new antivirals; review

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Delang, L.; Coelmont, L.; Neyts, J. Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care. Viruses 2010, 2, 826-866.

AMA Style

Delang L, Coelmont L, Neyts J. Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care. Viruses. 2010; 2(4):826-866.

Chicago/Turabian Style

Delang, Leen; Coelmont, Lotte; Neyts, Johan. 2010. "Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care." Viruses 2, no. 4: 826-866.

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert